Health News Releases

  • Today May 16
March 26, 2020 10:29
Tanner Pharma Group Announces LEUKINE EMERGENCY ACCESS PROGRAM (LEAP) to Provide Increased International Access to LEUKINE® (sargramostim)
Tanner Pharma Group today announced they are expanding their program by which the company provides access to LEUKINE® (sargramostim) in international markets. LEUKINE®, approved by the US FDA in 1991
March 25, 2020 15:31
Masimo and University Hospitals Jointly Announce Masimo SafetyNet™, a New Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts
Masimo (NASDAQ: MASI) and University Hospitals (UH), one of the largest health systems in Northeast Ohio, today jointly announced Masimo SafetyNet™, an innovative, economically scalable patient manage
March 25, 2020 14:26
In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic
Masimo (NASDAQ: MASI) today announced that, in response to current worldwide blood shortages driven by the coronavirus pandemic, it is making rainbow® licenses available for no additional charge to ho
March 24, 2020 17:26
ResMed Statement on COVID-19
ResMed (NYSE: RMD) (ASX: RMD) has released the following statement from CEO Mick Farrell regarding the evolving coronavirus disease (COVID-19) outbreak: “As a global leader in respiratory medicine,
March 23, 2020 11:53
Genomics Company Lucence Develops Viral Sample Collection Medical Device for COVID-19 Diagnosis and Surveillance
Molecular diagnostics company Lucence announced today the development of the SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) kit, a sample collection medical device to f
March 23, 2020 11:07
ViiV Healthcare Announces First Global Regulatory Approval of CABENUVA; the First Complete, Long-acting, Regimen for the Treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that Health Canada has approved CABENUVA, the first and
March 19, 2020 11:40
EUSA Pharma and the Papa Giovanni XXIII Hospital, Bergamo, Italy Announce Initiation of an Observational Case-control Study of Siltuximab in Patients with COVID-19 who have Developed Serious Respiratory Complications
EUSA Pharma, a global biopharmaceutical company focused on oncology and rare disease, today announced the initiation of the Papa Giovanni XXIII Hospital sponsored study of siltuximab, an interleukin (
March 19, 2020 11:12
Doxy.me Removes Telemedicine Barriers
Doxy.me, a free, secure telemedicine solution, stands ready to meet increased demand for a simple, convenient way for healthcare providers to meet with their patients remotely, promising to improve th
March 18, 2020 17:32
Chinese Hospitals use 3D Safety Goggles For Protection
Recently, a large safeguard instrument manufacturing enterprise in China used 200 Flashforge 3D printer Guider2 for 3D printing safety goggle production. The daily output of 3D printing safety goggles
March 18, 2020 17:06
The Lancet publishes papers from two studies of Takeda’s dengue vaccine candidate
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that The Lancet published two papers related to Takeda’s dengue vaccine candidate (TAK-003), reporting on results f
March 17, 2020 14:48
Arima Genomics Completes Customer Validation and Launches Arima-HiChIP Kits and Services
Arima Genomics, Inc., a biotechnology company focused on accelerating the adoption of genome structure information toward medical research, diagnosis and therapy, announced today the full commercial l
March 16, 2020 16:28
GN MEDI Antibacterial Spray Which Sterilizes 99.99 Percent of Influenza A Virus Is Launched
Ventex launched GN MEDI 99.9% antibacterial spray which is an eco-friendly and odorless product containing harmless minerals for sterilization and disinfection. Ventex is a technical company in Kor
March 16, 2020 09:27
U.S. FDA grants Fast Track designation to empagliflozin for the treatment of chronic kidney disease
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of empagliflozin to reduce the risk of kidney disease progression and cardiovascular death in adult
March 13, 2020 17:27
Siemens Korea donates 100 million won to help overcome novel coronavirus outbreak
Siemens Korea announced on March 13 that the company had donated 100 million won to the Korean Red Cross for supporting response efforts and stop the spread of COVID-19 outbreak. The donation was m
On World Kidney Day 2020, Fresenius Medical Care’s Corporate Social Responsibility program “The Kidn
March 12, 2020 18:10
The Kidney Kid Superhero Initiative Goes International on World Kidney Day
Fresenius Medical Care, the world’s leading provider of dialysis products and services, has today announced the international and digital expansion of its highly successful Asia Pacific-wide Corporate
March 12, 2020 15:35
Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance
Regulatory News: Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The c
March 12, 2020 11:19
RELIEF THERAPEUTICS Holding SA (SIX: RLF) announces the proposal of Prof. Jonathan Javitt, M.D., M.P.H., at the upcoming general assembly as Vice Chairman of the Board
RELIEF THERAPEUTICS Holding SA (SIX-RLF, “Relief” or the “Company”) announces today that Prof. Jonathan C. Javitt, MD, MPH will be proposed for election as Vice-Chairman of its Board of Directors at t
March 11, 2020 15:39
Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030
Patient Safety Movement Foundation (PSMF) - a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating a
March 11, 2020 14:36
Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide
Jesper Helmuth Larsen, CEO
March 09, 2020 11:34
AJ Vaccines To Develop Vaccine for COVID-19
“This endeavor reiterates our ambition to serve the global community, not only with existing effective high-quality vaccines, but also with the development of innovative new vaccines to answer the cur
March 06, 2020 17:11
Terns Pharmaceuticals to Present Data from an Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH
Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced it
March 05, 2020 11:28
Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclona
March 04, 2020 20:00
Takeda Completes Sale of Select OTC and Non-Core Assets to STADA
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products to STADA Arzneimittel AG (“STADA”
March 04, 2020 13:19
Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia
Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to an
March 03, 2020 16:29
Takeda Completes Sale of Select OTC and Non-Core Assets to Acino
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select over-the-counter (OTC) and prescription ph
25 per page50 per page75 per page100 per page